A judge has approved a bid to consolidate two shareholder class actions against Medibank over a cyberattack that affected 10 million customers, finding that having two firms on the record is better than a carriage contest.
A patient who gave his plastic surgeon a one-star review for a nose job is challenging a judgment that put him on the hook for $50,000 in defamation damages.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
A judge has endorsed Medibank’s bid to sue the OAIC so the court can weigh in on the health insurer’s bid to halt the regulator’s investigation in favour of a class action over its October data breach, saying the OAIC’s interference with the court proceedings could constitute a contempt of court.
A judge has approved a $41.45 million settlement in a pelvic mesh class action against manufacturers Covidien and TFS but has put off deciding on the costs of the firm that ran the case, saying it is “next to useless” when law firms appoint their own costs consultants.
Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.
Two class actions against Victorian aged care providers on behalf of families of residents who died due to alleged failures during the COVID-19 pandemic have appealed a ruling that rejected their bid for insurance and financial information to assist in mediation.
Junior doctors have notched an important victory in a class action alleging Peninsula Health failed to pay overtime hours, with a judge finding the healthcare provider liable to pay for overtime that was not expressly authorised.
A judge has directed a class action on behalf of 1,000 patients of Sydney-based plastic surgeon Daniel Lanzer and four of his associates to have another go at articulating claims that Lanzer’s clinic should be liable for allegedly ‘horrific’ complications.
Class actions throw up all manner of ethical conundrums, but a recent Federal Court decision has shined a light on the question of whether funders and law firms should take out loans to run class actions and whether they can charge the costs to group members.